AnnouncementsIntec Capital: Outcome of delisting committee meeting
AnnouncementsDynacons Technologies: Updates on open offer
AnnouncementsIntec Capital: Updates on delisting offer
AnnouncementsIndo-Asian Projects forfeits partly paid-up shares
AnnouncementsAshram Online.Com appoints D. Hemamalini as CFO
AnnouncementsCrompton Greaves: Updates on outcome of AGM
AnnouncementsKushal Tradelink: Outcome of AGM
AnnouncementsBajaj Finserv: Updates on outcome of AGM
No recommendations so far.What's your call on Brooks Labs today?
|Company Name||Last Price||%
|Dr Reddys Labs||2826.25||-0.43||2939.80||2128.40||48,140.94|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
IFGL Refractories Recommended on May 28th 2014
Recommended price 114.00 | Peak from reco 201.00 76.01%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Brooks Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 63.61 crore.The company has reported a standalone sales of Rs 18.82 crore and a Net Profit of Rs 2.00 crore for the quarter ended Mar 2014.
The company management includes Atul Ranchal - Chairman, Rajesh Mahajan - Managing Director, D S Maity - Director & CEO, Rajnish Bedi - Independent Director, Bhaskar Sharma - Additional Director.
It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS.
Its Registered office is at Village Kishanpura, Nalagarh Road,,Baddi Solan District,Himachal Pradesh - 174101.
Their Registrars are Link Intime India Pvt. Ltd.